Parametric Portfolio Associates LLC cut its holdings in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 8.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 595,208 shares of the medical instruments supplier’s stock after selling 57,128 shares during the quarter. Parametric Portfolio Associates LLC owned approximately 0.26% of DENTSPLY SIRONA worth $35,599,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Beach Investment Management LLC. purchased a new stake in shares of DENTSPLY SIRONA during the second quarter valued at about $3,057,000. Schwab Charles Investment Management Inc. lifted its position in shares of DENTSPLY SIRONA by 2.6% during the second quarter. Schwab Charles Investment Management Inc. now owns 729,311 shares of the medical instruments supplier’s stock valued at $47,289,000 after buying an additional 18,732 shares during the last quarter. Dupont Capital Management Corp purchased a new stake in shares of DENTSPLY SIRONA during the second quarter valued at about $116,000. Alps Advisors Inc. lifted its position in shares of DENTSPLY SIRONA by 0.3% during the second quarter. Alps Advisors Inc. now owns 7,523 shares of the medical instruments supplier’s stock valued at $488,000 after buying an additional 20 shares during the last quarter. Finally, Legal & General Group Plc lifted its position in shares of DENTSPLY SIRONA by 3.7% during the second quarter. Legal & General Group Plc now owns 1,116,435 shares of the medical instruments supplier’s stock valued at $72,389,000 after buying an additional 39,943 shares during the last quarter. 96.14% of the stock is owned by institutional investors.
XRAY has been the subject of several analyst reports. HC Wainwright lowered shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and set a $68.00 price target for the company. in a research report on Thursday, November 30th. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, October 30th. Deutsche Bank initiated coverage on shares of DENTSPLY SIRONA in a report on Friday, December 8th. They set a “buy” rating and a $81.00 price objective on the stock. JPMorgan Chase & Co. upgraded shares of DENTSPLY SIRONA from a “neutral” rating to an “overweight” rating and set a $75.00 price objective on the stock in a report on Wednesday, December 13th. Finally, Morgan Stanley restated an “overweight” rating and set a $69.00 price objective (up previously from $67.00) on shares of DENTSPLY SIRONA in a report on Friday, October 6th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and nine have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $69.15.
In other news, CFO Nicholas W. Alexos acquired 50,000 shares of the company’s stock in a transaction dated Monday, November 13th. The shares were acquired at an average price of $65.85 per share, with a total value of $3,292,500.00. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Francis J. Lunger sold 8,900 shares of the firm’s stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $65.90, for a total transaction of $586,510.00. The disclosure for this sale can be found here. 1.99% of the stock is currently owned by corporate insiders.
Shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) traded up $1.54 during trading hours on Friday, reaching $65.79. 1,667,132 shares of the company traded hands, compared to its average volume of 1,680,000. DENTSPLY SIRONA Inc has a one year low of $52.53 and a one year high of $68.98. The company has a current ratio of 2.32, a quick ratio of 1.59 and a debt-to-equity ratio of 0.21. The firm has a market cap of $15,110.00, a P/E ratio of -18.91, a PEG ratio of 2.36 and a beta of 1.31.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $978.99 million. During the same quarter in the prior year, the company earned $0.66 EPS. DENTSPLY SIRONA’s quarterly revenue was up 5.8% on a year-over-year basis. research analysts anticipate that DENTSPLY SIRONA Inc will post 2.65 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Friday, January 12th. Investors of record on Friday, December 29th were issued a $0.0875 dividend. The ex-dividend date of this dividend was Thursday, December 28th. This represents a $0.35 annualized dividend and a yield of 0.53%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -10.06%.
TRADEMARK VIOLATION NOTICE: “DENTSPLY SIRONA Inc (NASDAQ:XRAY) Stake Lessened by Parametric Portfolio Associates LLC” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/13/parametric-portfolio-associates-llc-decreases-stake-in-dentsply-sirona-inc-xray.html.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.